Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

EMMA Insider Trading

Emmaus Life Sciences, Inc. | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Emmaus Life Sciences, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2020-08-25 20:29 2020-08-21 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.59 250 $398 10,678,246 +0.0%
2020-08-21 19:56 2020-08-19 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.55 600 $931 10,677,996 +0.0%
2020-08-19 20:55 2020-08-17 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.61 1,250 $2,013 10,677,396 +0.0%
2020-08-17 19:37 2020-08-13 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.50 1,600 $2,401 10,676,146 +0.0%
2020-08-13 19:02 2020-08-11 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.62 1,153 $1,867 10,674,546 +0.0%
2020-06-23 20:42 2020-06-19 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.74 1,200 $2,088 10,673,393 +0.0%
2020-06-18 19:20 2020-06-16 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.67 1,000 $1,670 10,672,193 +0.0%
2020-06-16 20:37 2020-06-12 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.67 1,500 $2,505 10,671,193 +0.0%
2020-06-12 23:16 2020-06-10 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.76 6,300 $11,070 10,669,693 +0.1%
2020-06-10 20:52 2020-06-08 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.70 6,200 $10,548 10,663,393 +0.1%
2020-06-08 22:50 2020-06-04 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.60 5,700 $9,127 10,657,193 +0.1%
2020-06-04 20:12 2020-06-02 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.55 6,000 $9,280 10,651,493 +0.1%
2020-06-02 21:14 2020-05-29 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.55 5,700 $8,832 10,645,493 +0.1%
2020-05-29 20:54 2020-05-27 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.37 2,700 $3,689 10,639,793 +0.0%
2020-05-27 20:54 2020-05-22 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.38 1,600 $2,202 10,637,093 +0.0%
2020-05-22 20:30 2020-05-20 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.39 5,700 $7,929 10,635,493 +0.1%
2020-05-20 22:52 2020-05-18 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.35 500 $675 10,629,793 +0.0%
2020-05-19 00:21 2020-05-14 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.29 1,900 $2,451 10,629,293 +0.0%
2020-05-14 22:24 2020-05-12 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.30 5,300 $6,870 10,627,393 +0.0%
2020-05-12 01:42 2020-05-07 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.26 7,850 $9,911 10,622,093 +0.1%
2020-05-08 01:42 2020-05-05 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.32 4,000 $5,260 10,614,243 +0.0%
2020-05-06 02:10 2020-05-01 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.24 8,000 $9,890 10,610,243 +0.1%
2020-04-15 21:36 2020-04-13 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.68 17,300 $29,021 10,602,243 +0.2%
2020-04-10 21:05 2020-04-08 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.29 9,900 $12,736 10,584,943 +0.1%
2020-04-08 03:06 2020-04-03 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.25 13,000 $16,234 10,575,043 +0.1%
2020-04-03 21:43 2020-04-01 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.26 30,800 $38,783 10,562,043 +0.3%
2020-04-03 04:00 2020-03-31 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.21 13,200 $15,972 10,531,243 +0.1%
2020-04-01 21:43 2020-03-30 LEE WILLIS C Director, Officer - Vice Chairman & COO BUY $1.26 4,500 $5,665 33,000 +15.8%
2020-03-30 21:13 2020-03-26 LEE WILLIS C Director, Officer - Vice Chairman & COO BUY $1.14 6,800 $7,770 28,500 +31.3%
2020-03-31 01:21 2020-03-26 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.11 19,200 $21,364 10,518,043 +0.2%
2020-03-25 23:48 2020-03-23 LEE WILLIS C Director, Officer - Vice Chairman & COO BUY $1.32 1,500 $1,980 21,700 +7.4%
2020-03-24 02:57 2020-03-19 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.48 4,900 $7,252 10,498,843 +0.0%
2020-03-19 21:40 2020-03-17 LEE WILLIS C Director, Officer - Vice Chairman & COO BUY $1.59 6,550 $10,432 20,200 +48.0%
2020-03-19 02:27 2020-03-16 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.54 7,200 $11,097 10,493,943 +0.1%
2020-03-14 01:37 2020-03-11 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.60 11,600 $18,570 10,486,743 +0.1%
2020-03-12 23:09 2020-03-10 LEE WILLIS C Director, Officer - Vice Chairman & COO BUY $1.68 2,500 $4,204 13,650 +22.4%
2020-03-11 00:05 2020-03-06 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.44 42,850 $61,897 10,475,143 +0.4%
2020-03-10 02:10 2020-03-05 LEE WILLIS C Director, Officer - Vice Chairman & COO BUY $1.37 11,150 $15,312 11,150 +100.0%
2020-03-06 03:10 2020-03-03 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.67 23,750 $39,734 10,432,293 +0.2%
2020-02-22 03:51 2020-02-19 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.80 48,000 $86,582 10,408,543 +0.5%
2020-02-19 02:10 2020-02-13 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.82 22,750 $41,314 10,360,543 +0.2%
2020-02-14 21:33 2020-02-12 LEE WILLIS C Director, Officer - Vice Chairman & COO BUY $1.77 3,000 $5,305 215,624 +1.4%
2020-02-13 02:49 2020-02-10 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.80 31,100 $56,117 10,337,793 +0.3%
2020-02-10 20:25 2020-02-06 LEE WILLIS C Director, Officer - Vice Chairman & COO BUY $1.31 4,550 $5,961 212,624 +2.2%
2020-02-10 20:29 2020-02-06 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $1.28 18,800 $23,998 10,306,693 +0.2%
2019-11-05 00:15 2019-11-01 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $2.98 16,500 $49,170 10,287,893 +0.2%
2019-11-02 01:19 2019-10-31 LEE WILLIS C Director, Officer - Vice Chairman & COO BUY $2.94 1,800 $5,284 208,074 +0.9%
2019-11-01 21:31 2019-10-30 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $2.69 5,500 $14,815 10,271,393 +0.1%
2019-10-21 21:03 2019-10-18 Niihara Yutaka Director, Officer, 10% owner - Chairman and CEO BUY $2.78 7,000 $19,460 10,265,893 +0.1%
2019-10-18 23:03 2019-10-16 LEE WILLIS C Director, Officer - Vice Chairman & COO BUY $2.65 7,890 $20,893 206,274 +4.0%
SHOW ENTRIES

How to Interpret $EMMA Trades

Not every insider transaction in Emmaus Life Sciences, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $EMMA shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for EMMA

Insider activity data for Emmaus Life Sciences, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $EMMA, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.